相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alzheimer's disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers
Cristina Carvalho et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents
Dmitry Petrov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Insulin Neuroprotection and the Mechanisms
Li-Yun Yu et al.
CHINESE MEDICAL JOURNAL (2015)
DPP-4 Inhibitor Linagliptin Attenuates Aβ-induced Cytotoxicity through Activation of AMPK in Neuronal Cells
Edy Kornelius et al.
CNS NEUROSCIENCE & THERAPEUTICS (2015)
Parkinson's disease and enhanced inflammatory response
Iva Stojkovska et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Early intervention with glucagon-like peptide 1 analog liraglutide prevents tau hyperphosphorylation in diabetic db/db mice
De-Lin Ma et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Restoration of Cerebral and Systemic Microvascular Architecture in APP/PS1 Transgenic Mice Following Treatment with Liraglutide™
Patricia Kelly et al.
MICROCIRCULATION (2015)
NEUROPROTECTIVE EFFECTS OF LIXISENATIDE AND LIRAGLUTIDE IN THE 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MOUSE MODEL OF PARKINSON'S DISEASE
W. Liu et al.
NEUROSCIENCE (2015)
The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease
Henrik H. Hansen et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson's Disease
Iciar Aviles-Olmos et al.
JOURNAL OF PARKINSONS DISEASE (2014)
First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer's disease
Christian Hoelscher
ALZHEIMERS & DEMENTIA (2014)
Exenatide as a potential treatment for patients with Parkinson's disease: First steps into the clinic
Thomas Foltynie et al.
ALZHEIMERS & DEMENTIA (2014)
Evaluation of neuroprotective effect of glucagon-like peptide 1 analogs using neuroimaging
Grazia D. Femminella et al.
ALZHEIMERS & DEMENTIA (2014)
The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease
Christian Hoelscher
ALZHEIMERS & DEMENTIA (2014)
How does brain insulin resistance develop in Alzheimer's disease?
Fernanda G. De Felice et al.
ALZHEIMERS & DEMENTIA (2014)
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease
Konrad Talbot et al.
ALZHEIMERS & DEMENTIA (2014)
At the Centennial of Michaelis and Menten, Competing Michaelis-Menten Steps Explain Effect of GLP-1 on Blood-Brain Transfer and Metabolism of Glucose
Michael Gejl et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation
K. Pabreja et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease
Fernanda G. De Felice et al.
DIABETES (2014)
Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: Differences and similarities
Asger Lund et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2014)
Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease
Paula L. McClean et al.
NEUROPHARMACOLOGY (2014)
Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches
Inelia Morales et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Insulin Has Multiple Antiamyloidogenic Effects on Human Neuronal Cells
Giuseppe Pandini et al.
ENDOCRINOLOGY (2013)
Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease
Jayasankar Kosaraju et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Saxagliptin: A dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease
Jayasankar Kosaraju et al.
NEUROPHARMACOLOGY (2013)
Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals
M. Bomba et al.
CELL DEATH & DISEASE (2013)
Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial
Suzanne Craft et al.
ARCHIVES OF NEUROLOGY (2012)
The Classification of Microglial Activation Phenotypes on Neurodegeneration and Regeneration in Alzheimer's Disease Brain
Megan M. Varnum et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2012)
Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation
Daisuke Shiraishi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
Kerry Hunter et al.
BMC NEUROSCIENCE (2012)
Metabolic syndrome, mild cognitive impairment and Alzheimer's disease-The emerging role of systemic low-grade inflammation and adiposity
Blazej Misiak et al.
BRAIN RESEARCH BULLETIN (2012)
Metabolic Alterations Induced by Sucrose Intake and Alzheimer's Disease Promote Similar Brain Mitochondrial Abnormalities
Cristina Carvalho et al.
DIABETES (2012)
(Val8) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains
Lin Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia
Michael Gejl et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice
Simon Gengler et al.
NEUROBIOLOGY OF AGING (2012)
被撤回的出版物: Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson's disease with combined noradrenergic and serotonergic lesions (Retracted article. See vol. 47, pg. 221, 2013)
N. Rampersaud et al.
NEUROPEPTIDES (2012)
Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease
Darin Jaturapatporn et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Aβ Oligomer-Induced Synapse Degeneration in Alzheimer's Disease
Kyle C. Wilcox et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2011)
Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control
P. Anagnostis et al.
DIABETES OBESITY & METABOLISM (2011)
Insulin resistance impairs nigrostriatal dopamine function
J. K. Morris et al.
EXPERIMENTAL NEUROLOGY (2011)
The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
Paula L. McClean et al.
JOURNAL OF NEUROSCIENCE (2011)
Epidemiology of Alzheimer disease
Christiane Reitz et al.
NATURE REVIEWS NEUROLOGY (2011)
Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
Tomohiko Sato et al.
NEUROBIOLOGY OF AGING (2011)
Brain insulin signaling: A key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes
Ewan C. McNay et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2011)
Glucose tolerance status and risk of dementia in the community The Hisayama Study
T. Ohara et al.
NEUROLOGY (2011)
Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer's prone mice
Michele D'Amico et al.
EXPERIMENTAL GERONTOLOGY (2010)
Is Brain Amyloid Production a Cause or a Result of Dementia of The Alzheimer's Type?
Robert G. Struble et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Revising the definition of Alzheimer's disease: a new lexicon
Bruno Dubois et al.
LANCET NEUROLOGY (2010)
New roles for insulin-like hormones in neuronal signalling and protection: New hopes for novel treatments of Alzheimer's disease?
Christian Hoelscher et al.
NEUROBIOLOGY OF AGING (2010)
Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
Aileen M. Moloney et al.
NEUROBIOLOGY OF AGING (2010)
Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance
Ewan C. McNay et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2010)
Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease
Talib Abbas et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease
Wei-Qin Zhao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Modulation of Microglial Innate Immunity in Alzheimer's Disease by Activation of Peroxisome Proliferator-activated Receptor Gamma
Feng-Shiun Shie et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Conversion of amyloid positive and negative MCI to AD over 3 years An 11C-PIB PET study
A. Okello et al.
NEUROLOGY (2009)
Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers
Fernanda G. De Felice et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
Yazhou Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mining incretin hormone pathways for novel therapies
Rhonda D. Wideman et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2009)
Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease
Goran Bertilsson et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study
Paul Edison et al.
NEUROBIOLOGY OF DISEASE (2008)
Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo
Shu-Ling Chiu et al.
NEURON (2008)
Amyloid precursor protein expression is upregulated in adipocytes in obesity
Yong-Ho Lee et al.
OBESITY (2008)
β-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic β cells
Noriyuki Sonoda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
PPARs in the brain
Michael T. Heneka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy
TracyAnn Perry et al.
EXPERIMENTAL NEUROLOGY (2007)
Glucagon-like peptide-1 inhibits LPS-induced IL-1β production in cultured rat astrocytes
Takashi Iwai et al.
NEUROSCIENCE RESEARCH (2006)
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms
M Sastre et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2006)
Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology
JJM Hoozemans et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2006)
Neuronal insulin signal transduction mechanisms in diabetes phenotypes
LP Reagan
NEUROBIOLOGY OF AGING (2005)
Peripheral hyperinsulinemia promotes tau phosphorylation in vivo
S Freude et al.
DIABETES (2005)
Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice
Michael T. Heneka et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Synaptic targeting by Alzheimer's-related amyloid β oligomers
PN Lacor et al.
JOURNAL OF NEUROSCIENCE (2004)
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
MJ During et al.
NATURE MEDICINE (2003)
Glucagon-like peptide-1 decreases endogenous amyloid-β peptide (Aβ) levels and protects hippocampal neurons from death induced by Aβ and iron
T Perry et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
A novel neutrotrophic property of glucagon-like peptide 1: A promoter of nerve growth factor-mediated differentiation in PC12 cells
T Perry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
分享论文
